Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.04.2015 | Case report

Interferon-β-1b

Sweet's syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Kim YJ, et al. Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis. International Journal of Dermatology 54: 456-458, No. 4, Apr 2015 - South KoreaCrossRefPubMed Kim YJ, et al. Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis. International Journal of Dermatology 54: 456-458, No. 4, Apr 2015 - South KoreaCrossRefPubMed
Metadaten
Titel
Interferon-β-1b
Sweet's syndrome: case report
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-9966-5

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Levamisole

Case report

Erlotinib

Case report

Various drugs

Case report

Paroxetine

Case report

Everolimus